TY - JOUR
T1 - Rheumatic heart disease anno 2020
T2 - Impacts of gender and migration on epidemiology and management
AU - Mutagaywa, Reuben K.
AU - Wind, Anna Maria
AU - Kamuhabwa, Apolinary
AU - Cramer, Maarten J.
AU - Chillo, Pilly
AU - Chamuleau, Steven
N1 - Publisher Copyright:
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
PY - 2020/12
Y1 - 2020/12
N2 - Background: The epidemiology and management of diseases can be influenced by social demographic factors. Gender and migration are among these factors. Methods: We aimed at reviewing the impacts of gender and migration on rheumatic heart disease (RHD) epidemiology and management by a nonsystematic literature review of published studies on RHD worldwide. Our PubMed search terms included RHD pathophysiology, diagnosis, complications, management or prevention, combined with words ‘rheumatic mitral stenosis (MS)’, ‘outcomes after percutaneous balloon mitral valvuloplasty (PBMV)’, ‘gender or sex difference’ and ‘migration’. The reporting of this study conforms to SANRA (the Scale for Assessment of Narrative Review Articles) guidelines. Results: We retrieved eight studies about the impact of sex on outcomes after PBMV. All of these studies showed a female predominance for RHD. Two studies showed that there is no impact, three studies showed female sex as a predictor of poor outcomes, and the other three showed male sex a predictor of poor outcomes. Although RHD is reported to be eradicated in the developed countries, 2.1% of refugees recently screened for RHD in Italy were found to have subclinical RHD. This prevalence is similar to those found in India (2.0%), Cambodia (2.2%) and Mozambique (3%). Conclusions: There are contradicting results for outcomes after PBMV between males and females. It is not clear whether sex difference plays a role in pathophysiology, diagnosis, management and prognosis of MS. Migration has impacts on epidemiology and management of RHD. Further studies are required in these two fields to explore their relationship to RHD.
AB - Background: The epidemiology and management of diseases can be influenced by social demographic factors. Gender and migration are among these factors. Methods: We aimed at reviewing the impacts of gender and migration on rheumatic heart disease (RHD) epidemiology and management by a nonsystematic literature review of published studies on RHD worldwide. Our PubMed search terms included RHD pathophysiology, diagnosis, complications, management or prevention, combined with words ‘rheumatic mitral stenosis (MS)’, ‘outcomes after percutaneous balloon mitral valvuloplasty (PBMV)’, ‘gender or sex difference’ and ‘migration’. The reporting of this study conforms to SANRA (the Scale for Assessment of Narrative Review Articles) guidelines. Results: We retrieved eight studies about the impact of sex on outcomes after PBMV. All of these studies showed a female predominance for RHD. Two studies showed that there is no impact, three studies showed female sex as a predictor of poor outcomes, and the other three showed male sex a predictor of poor outcomes. Although RHD is reported to be eradicated in the developed countries, 2.1% of refugees recently screened for RHD in Italy were found to have subclinical RHD. This prevalence is similar to those found in India (2.0%), Cambodia (2.2%) and Mozambique (3%). Conclusions: There are contradicting results for outcomes after PBMV between males and females. It is not clear whether sex difference plays a role in pathophysiology, diagnosis, management and prognosis of MS. Migration has impacts on epidemiology and management of RHD. Further studies are required in these two fields to explore their relationship to RHD.
KW - gender
KW - impact
KW - migration
KW - review
KW - rheumatic mitral stenosis
KW - sex
UR - http://www.scopus.com/inward/record.url?scp=85089889324&partnerID=8YFLogxK
U2 - 10.1111/eci.13374
DO - 10.1111/eci.13374
M3 - Review article
C2 - 32789848
AN - SCOPUS:85089889324
SN - 0014-2972
VL - 50
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 12
M1 - e13374
ER -